Search by Drug Name or NDC

    NDC 60986-1008-03 Cholenest 2; 1; 8; 1; 8; 2; 1; 6; 1; 2 [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL Details

    Cholenest 2; 1; 8; 1; 8; 2; 1; 6; 1; 2 [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL

    Cholenest is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Marco Pharma International LLC.. The primary component is BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; COPPER; FRANGULA PURSHIANA BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MORELLA CERIFERA ROOT BARK; SILYBUM MARIANUM SEED; SODIUM SULFATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT.

    Product Information

    NDC 60986-1008
    Product ID 60986-1008_d2bfd2b8-d3b7-e3bf-e053-2995a90a2901
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Cholenest
    Proprietary Name Suffix n/a
    Non-Proprietary Name Rhamnus purshiana, Carduus marianus, Taraxacum officinale, Chelidonium majus, Leptandra virginica, Myrica cerifera, Berberis vulgaris, Natrum sulphuricum, Magnesia phosphorica, Cuprum metallicum
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 2; 1; 8; 1; 8; 2; 1; 6; 1; 2
    Active Ingredient Units [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL; [hp_X]/100mL
    Substance Name BERBERIS VULGARIS ROOT BARK; CHELIDONIUM MAJUS; COPPER; FRANGULA PURSHIANA BARK; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MORELLA CERIFERA ROOT BARK; SILYBUM MARIANUM SEED; SODIUM SULFATE; TARAXACUM OFFICINALE; VERONICASTRUM VIRGINICUM ROOT
    Labeler Name Marco Pharma International LLC.
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibit Ov
    DEA Schedule n/a
    Marketing Category UNAPPROVED HOMEOPATHIC
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 60986-1008-03 (60986100803)

    NDC Package Code 60986-1008-3
    Billing NDC 60986100803
    Package 50 mL in 1 BOTTLE, GLASS (60986-1008-3)
    Marketing Start Date 2018-02-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 4b89ffcb-318b-416d-b13c-19fb94c2af70 Details

    Revised: 12/2021